Bahri Bilir is a Gastroenterology physician affiliated with Adventist HealthCare. OpenAlex indexes 29 publications with 1,106 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1001 Southpark Dr
Littleton, CO 801205641
Telephone
303-722-8987Registry record last updated 10 Oct 2017.
Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20259 payments
- ABBVIE INC.Program year202517 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
85.1%Proton pump inhibitor61%Omeprazole81%Pantoprazole Sodium19%Part D≥73 patientsOsmotic Laxative13%Gavilyte-G40%Lactulose25%Gavilyte-C18%Peg-3350 And Electrolytes18%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
9.7%Purine Antimetabolite4.5%Azathioprine100%Part D<11 patientsInterleukin-12 Antagonist2.7%Stelara100%Part D<11 patients+ 1 more class in this area
Anti-infectives
2.7%Nucleoside and nucleotide reverse transcriptase inhibitors2.7%Vemlidy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1994–2002 per NIH RePORTER. The latest:
- OPC 41061 IN PTS WITH HYPONATREMIA SECONDARY TO LIVER DISEASE
University of Colorado Denver
FY2002$190,747M01RR000051 - OPC 41061 IN PTS WITH HYPONATREMIA SECONDARY TO LIVER DISEASE
University of Colorado Denver
FY2001$190,747M01RR000051 - OPC 41061 IN PTS WITH HYPONATREMIA SECONDARY TO LIVER DISEASE
University of Colorado Denver
FY2001M01RR000051
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Dibianco, MD
Adventist HealthCare
Homam Ibrahim, MD
Adventist HealthCare
Daniel Boken, MD
Adventist HealthCare
Avantika Chenna, MD
Adventist HealthCare
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”